Review





Similar Products

93
Miltenyi Biotec rea611 2ul 2e5 cells ccr7 fitc miltenyi
Rea611 2ul 2e5 Cells Ccr7 Fitc Miltenyi, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fitc+anti+cd45ro/CD45RO+Antibody%2C+anti-human%2C+REAfinity/pmc12081906__41467_2025_59810_MOESM2_ESM-55-300-305
Average 93 stars, based on 1 article reviews
rea611 2ul 2e5 cells ccr7 fitc miltenyi - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

90
Thermo Fisher anti-human cd45ro-fitc
Anti Human Cd45ro Fitc, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fitc+anti+cd45ro/anti+cd45ro/pm39331727-199-12-16
Average 90 stars, based on 1 article reviews
anti-human cd45ro-fitc - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

95
Miltenyi Biotec n a cd45ro fitc
N A Cd45ro Fitc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fitc+anti+cd45ro/PGP9%2E5+(UCH-L1)+Antibody%2C+anti-human%2C+PE%2C+REAdye_lease/pm39226901-240-246-253
Average 95 stars, based on 1 article reviews
n a cd45ro fitc - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier

95
Miltenyi Biotec anti human cd45ro fitc
Anti Human Cd45ro Fitc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fitc+anti+cd45ro/PGP9%2E5+(UCH-L1)+Antibody%2C+anti-human%2C+PE%2C+REAdye_lease/pmc11291333-111-26-29
Average 95 stars, based on 1 article reviews
anti human cd45ro fitc - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier

92
Cytek Biosciences anti cd45ro
Anti Cd45ro, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fitc+anti+cd45ro/FITC+Anti-Human+CD45RO/pm38146769-42-15-17
Average 92 stars, based on 1 article reviews
anti cd45ro - by Bioz Stars, 2026-09
92/100 stars
  Buy from Supplier

90
ImmunoTools anti-human cd45ro-fitc
Anti Human Cd45ro Fitc, supplied by ImmunoTools, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fitc+anti+cd45ro/cd45+fitc+antibody/pmc11067362-283-15-17
Average 90 stars, based on 1 article reviews
anti-human cd45ro-fitc - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
ImmunoTools anti-human cd45ro mouse igg2a - fitc

Anti Human Cd45ro Mouse Igg2a Fitc, supplied by ImmunoTools, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fitc+anti+cd45ro/cd45+fitc+antibody/pmc11067362-5-0-7
Average 90 stars, based on 1 article reviews
anti-human cd45ro mouse igg2a - fitc - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

86
Thermo Fisher anti human cd45ro fitc
Tscm cells from the blood and MLNs of patients with CD with treatment showed distinct IFN-γ expression levels. (A) Flow cytometric analysis of PBMCs and lymphocytes from patients with CD; Tscm cells are defined as CD3 + CD4 + CD45RA + <t>/CD45RO</t> − CCR7 + CD62L + CD95 + CD122 + or CD3 + CD8 + /CD4 − CD45RA + /CD45RO − CCR7 + CD62L + CD95 + CD122 + cells. The frequencies of CD4 + Tscm and CD8 + Tscm cells in PBMCs and healthy MLNs and the lesions of MLNs from patients with CD with treatment. (B) Representative flow cytometric analysis of IFN-γ-, IL-17-, and TNF-α-producing CD4 + Tscm and CD8 + Tscm cells in PBMCs and MLNs from patients with CD and healthy donors. (C) The mean frequencies (± SEM) of IFN-γ-, IL-17-, and TNF-α-expressing CD4 + Tscm and CD8 + Tscm cells in the blood and MLNs. *, P<0.05; unpaired Student t -test. (D) Plot showing the frequencies of IFN-γ-, IL-17-, and TNF-α-secreting CD4 + Tscm and CD8 + Tscm cells in blood and MLNs from patients with CD and healthy donors expressed as the mean ± SEM. *, P<0.05; unpaired Student t -test. Tscm, stem cell-like memory T; HD-PBMCs, PBMCs from healthy donors; PBMCs, peripheral blood mononuclear cells; CD-PBMCs, PBMCs from patients with CD; CD, Crohn’s disease; N-M-Lys, healthy MLNs from patients with CD; MLNs, mesenteric lymph nodes; CD-M-Lys, lesions of the MLNs from patients with CD; SSC, side scatter; IFN-γ, interferon-γ; IL, interleukin; TNF-α, tumor necrosis factor-α; SEM, standard error of the mean.
Anti Human Cd45ro Fitc, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fitc+anti+cd45ro/pmc11074482-79-60-64
Average 86 stars, based on 1 article reviews
anti human cd45ro fitc - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

86
Danaher Inc cd45ro fitc
Tscm cells from the blood and MLNs of patients with CD with treatment showed distinct IFN-γ expression levels. (A) Flow cytometric analysis of PBMCs and lymphocytes from patients with CD; Tscm cells are defined as CD3 + CD4 + CD45RA + <t>/CD45RO</t> − CCR7 + CD62L + CD95 + CD122 + or CD3 + CD8 + /CD4 − CD45RA + /CD45RO − CCR7 + CD62L + CD95 + CD122 + cells. The frequencies of CD4 + Tscm and CD8 + Tscm cells in PBMCs and healthy MLNs and the lesions of MLNs from patients with CD with treatment. (B) Representative flow cytometric analysis of IFN-γ-, IL-17-, and TNF-α-producing CD4 + Tscm and CD8 + Tscm cells in PBMCs and MLNs from patients with CD and healthy donors. (C) The mean frequencies (± SEM) of IFN-γ-, IL-17-, and TNF-α-expressing CD4 + Tscm and CD8 + Tscm cells in the blood and MLNs. *, P<0.05; unpaired Student t -test. (D) Plot showing the frequencies of IFN-γ-, IL-17-, and TNF-α-secreting CD4 + Tscm and CD8 + Tscm cells in blood and MLNs from patients with CD and healthy donors expressed as the mean ± SEM. *, P<0.05; unpaired Student t -test. Tscm, stem cell-like memory T; HD-PBMCs, PBMCs from healthy donors; PBMCs, peripheral blood mononuclear cells; CD-PBMCs, PBMCs from patients with CD; CD, Crohn’s disease; N-M-Lys, healthy MLNs from patients with CD; MLNs, mesenteric lymph nodes; CD-M-Lys, lesions of the MLNs from patients with CD; SSC, side scatter; IFN-γ, interferon-γ; IL, interleukin; TNF-α, tumor necrosis factor-α; SEM, standard error of the mean.
Cd45ro Fitc, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fitc+anti+cd45ro/pmc10797701-80-57-59
Average 86 stars, based on 1 article reviews
cd45ro fitc - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

Image Search Results


Journal: iScience

Article Title: Migration of human T cells can be differentially directed by electric fields depending on the extracellular microenvironment

doi: 10.1016/j.isci.2024.109746

Figure Lengend Snippet:

Article Snippet: Anti-human CD45RO mouse IgG2a - FITC , ImmunoTools , Cat#: 21336453 Lot: 277066.

Techniques: Recombinant, Cell Isolation, Isolation, Software

Tscm cells from the blood and MLNs of patients with CD with treatment showed distinct IFN-γ expression levels. (A) Flow cytometric analysis of PBMCs and lymphocytes from patients with CD; Tscm cells are defined as CD3 + CD4 + CD45RA + /CD45RO − CCR7 + CD62L + CD95 + CD122 + or CD3 + CD8 + /CD4 − CD45RA + /CD45RO − CCR7 + CD62L + CD95 + CD122 + cells. The frequencies of CD4 + Tscm and CD8 + Tscm cells in PBMCs and healthy MLNs and the lesions of MLNs from patients with CD with treatment. (B) Representative flow cytometric analysis of IFN-γ-, IL-17-, and TNF-α-producing CD4 + Tscm and CD8 + Tscm cells in PBMCs and MLNs from patients with CD and healthy donors. (C) The mean frequencies (± SEM) of IFN-γ-, IL-17-, and TNF-α-expressing CD4 + Tscm and CD8 + Tscm cells in the blood and MLNs. *, P<0.05; unpaired Student t -test. (D) Plot showing the frequencies of IFN-γ-, IL-17-, and TNF-α-secreting CD4 + Tscm and CD8 + Tscm cells in blood and MLNs from patients with CD and healthy donors expressed as the mean ± SEM. *, P<0.05; unpaired Student t -test. Tscm, stem cell-like memory T; HD-PBMCs, PBMCs from healthy donors; PBMCs, peripheral blood mononuclear cells; CD-PBMCs, PBMCs from patients with CD; CD, Crohn’s disease; N-M-Lys, healthy MLNs from patients with CD; MLNs, mesenteric lymph nodes; CD-M-Lys, lesions of the MLNs from patients with CD; SSC, side scatter; IFN-γ, interferon-γ; IL, interleukin; TNF-α, tumor necrosis factor-α; SEM, standard error of the mean.

Journal: Translational Gastroenterology and Hepatology

Article Title: Crohn’s disease treatment and memory T-cell subset changes: insights from a case series

doi: 10.21037/tgh-23-21

Figure Lengend Snippet: Tscm cells from the blood and MLNs of patients with CD with treatment showed distinct IFN-γ expression levels. (A) Flow cytometric analysis of PBMCs and lymphocytes from patients with CD; Tscm cells are defined as CD3 + CD4 + CD45RA + /CD45RO − CCR7 + CD62L + CD95 + CD122 + or CD3 + CD8 + /CD4 − CD45RA + /CD45RO − CCR7 + CD62L + CD95 + CD122 + cells. The frequencies of CD4 + Tscm and CD8 + Tscm cells in PBMCs and healthy MLNs and the lesions of MLNs from patients with CD with treatment. (B) Representative flow cytometric analysis of IFN-γ-, IL-17-, and TNF-α-producing CD4 + Tscm and CD8 + Tscm cells in PBMCs and MLNs from patients with CD and healthy donors. (C) The mean frequencies (± SEM) of IFN-γ-, IL-17-, and TNF-α-expressing CD4 + Tscm and CD8 + Tscm cells in the blood and MLNs. *, P<0.05; unpaired Student t -test. (D) Plot showing the frequencies of IFN-γ-, IL-17-, and TNF-α-secreting CD4 + Tscm and CD8 + Tscm cells in blood and MLNs from patients with CD and healthy donors expressed as the mean ± SEM. *, P<0.05; unpaired Student t -test. Tscm, stem cell-like memory T; HD-PBMCs, PBMCs from healthy donors; PBMCs, peripheral blood mononuclear cells; CD-PBMCs, PBMCs from patients with CD; CD, Crohn’s disease; N-M-Lys, healthy MLNs from patients with CD; MLNs, mesenteric lymph nodes; CD-M-Lys, lesions of the MLNs from patients with CD; SSC, side scatter; IFN-γ, interferon-γ; IL, interleukin; TNF-α, tumor necrosis factor-α; SEM, standard error of the mean.

Article Snippet: The following panel of mouse anti-human monoclonal antibodies (mAbs) used were all purchased from BD Biosciences (Franklin Lakes, NJ, USA) or eBioscience (San Diego, CA, USA): anti-human CD3-APC.Cy7 (cat. 557832, SK7; BD Biosciences), anti-human CD4-Percp.Cy5.5 (cat. 560650, RPA-T4; BD Biosciences), anti-human CD8-Alexa Fluor 700 (cat. 56-0088-42, RPA-T8; eBioscience), anti-human CCR7-PE.eFluor610 (cat. 61-1979-42, 3D12; eBioscience), anti-human CD62L-APC (cat. 17-0629-42, DREG56; eBioscience), anti-human CD45RO-FITC (11-0457-42, UCHL1; eBioscience), anti-human CD95-PE.Cy7 (cat. 561633, DX2; BD Biosciences), anti-human CD103-APC (cat. 17-1037-41, Ber-ACT8; eBioscience), and anti-human CD122-PE (cat. 554525; BD Biosciences).

Techniques: Expressing

The frequencies of Trm-cell subsets in lymph nodes from patients with CD with treatment. (A) Flow cytometric analysis of CD69 and/or CD103 expression on CD3 + CD4 + Trm and CD3 + CD8 + Trm cells from patients with CD; Trm cells and their subsets are defined as CD3 + CD4 + CD45RO + CD69 + CD103 + , CD3 + CD8 + CD45RO + CD69 + CD103 + , CD3 + CD4 + CD45RO + CD69 + , CD3 + CD8 + CD45RO + CD69 + , CD3 + CD4 + CD45RO + CD103 + , or CD3 + CD8 + CD45RO + CD103 + cells. (B) The frequencies of CD4 + CD69 + CD103 + Trm and CD8 + CD69 + CD103 + Trm cells in the small intestinal mucosa and MLNs from patients with CD with treatment. **, P<0.01; ***, P<0.001; unpaired Student t -test. (C) The proportions of CD4 + CD69 + CD103 − Trm and CD8 + CD69 + CD103 − Trm cells in the small intestinal mucosa and MLNs from patients with CD with treatment. *, P<0.05; unpaired Student t -test. (D) The fractions of CD4 + CD103 + CD69 − Trm and CD8 + CD103 + CD69 − Trm cells in the small intestinal mucosa and MLNs from patients with CD with treatment. *, P<0.05; **, P<0.01; unpaired Student t -test. Trm, tissue-resident memory T; N-SIM, healthy small intestinal mucosa from patients with CD; CD, Crohn’s disease; CD-SIM, lesions from the small intestinal mucosa from patients with CD; N-M-Lys, healthy MLNs from patients with CD; MLNs, mesenteric lymph nodes; CD-M-Lys, lesions of the MLNs from patients with CD.

Journal: Translational Gastroenterology and Hepatology

Article Title: Crohn’s disease treatment and memory T-cell subset changes: insights from a case series

doi: 10.21037/tgh-23-21

Figure Lengend Snippet: The frequencies of Trm-cell subsets in lymph nodes from patients with CD with treatment. (A) Flow cytometric analysis of CD69 and/or CD103 expression on CD3 + CD4 + Trm and CD3 + CD8 + Trm cells from patients with CD; Trm cells and their subsets are defined as CD3 + CD4 + CD45RO + CD69 + CD103 + , CD3 + CD8 + CD45RO + CD69 + CD103 + , CD3 + CD4 + CD45RO + CD69 + , CD3 + CD8 + CD45RO + CD69 + , CD3 + CD4 + CD45RO + CD103 + , or CD3 + CD8 + CD45RO + CD103 + cells. (B) The frequencies of CD4 + CD69 + CD103 + Trm and CD8 + CD69 + CD103 + Trm cells in the small intestinal mucosa and MLNs from patients with CD with treatment. **, P<0.01; ***, P<0.001; unpaired Student t -test. (C) The proportions of CD4 + CD69 + CD103 − Trm and CD8 + CD69 + CD103 − Trm cells in the small intestinal mucosa and MLNs from patients with CD with treatment. *, P<0.05; unpaired Student t -test. (D) The fractions of CD4 + CD103 + CD69 − Trm and CD8 + CD103 + CD69 − Trm cells in the small intestinal mucosa and MLNs from patients with CD with treatment. *, P<0.05; **, P<0.01; unpaired Student t -test. Trm, tissue-resident memory T; N-SIM, healthy small intestinal mucosa from patients with CD; CD, Crohn’s disease; CD-SIM, lesions from the small intestinal mucosa from patients with CD; N-M-Lys, healthy MLNs from patients with CD; MLNs, mesenteric lymph nodes; CD-M-Lys, lesions of the MLNs from patients with CD.

Article Snippet: The following panel of mouse anti-human monoclonal antibodies (mAbs) used were all purchased from BD Biosciences (Franklin Lakes, NJ, USA) or eBioscience (San Diego, CA, USA): anti-human CD3-APC.Cy7 (cat. 557832, SK7; BD Biosciences), anti-human CD4-Percp.Cy5.5 (cat. 560650, RPA-T4; BD Biosciences), anti-human CD8-Alexa Fluor 700 (cat. 56-0088-42, RPA-T8; eBioscience), anti-human CCR7-PE.eFluor610 (cat. 61-1979-42, 3D12; eBioscience), anti-human CD62L-APC (cat. 17-0629-42, DREG56; eBioscience), anti-human CD45RO-FITC (11-0457-42, UCHL1; eBioscience), anti-human CD95-PE.Cy7 (cat. 561633, DX2; BD Biosciences), anti-human CD103-APC (cat. 17-1037-41, Ber-ACT8; eBioscience), and anti-human CD122-PE (cat. 554525; BD Biosciences).

Techniques: Expressing